Clobetasol's Influence on the Management and Cost of Skin Overgrowth Associated with the Bone-Anchored Hearing Aid

REFERENCES

1. ↵
   1. Cochlear Limited

   (2015) Baha candidate brochure, http://www.cochlear.com/wps/wcm/connect/ ced7774e-0a71-4fbb-bbec-701f4911cfe3/GD2235%20CL %20-%20Baha%20Candidate%20Brochure%20A4%2016pp_LR.pdf?MOD=AJPERES, Accessed June 1.
2. ↵
   1. Falcone MT,
   2. Kaylie DM,
   3. Labadie RF,
   4. Haynes DS.

   (12, 2008) Bone-anchored hearing aid abutment skin overgrowth reduction with clobetasol. Otolaryngol Head Neck Surg 139(6):829–832, pmid:19041511, doi: 10.1016/j.otohns.2008.08.021.

   OpenUrlCrossRefPubMed
3. ↵
   1. Hobson JC,
   2. Roper AJ,
   3. Andrew R,
   4. Rothera MP,
   5. Hill P,
   6. Green KM.

   (2, 2010) Complications of bone-anchored hearing aid implantation. J Laryngol Otol 124(2):132–136, pmid:19968889, doi: 10.1017/S0022215109991708.

   OpenUrlCrossRefPubMed
4. ↵
   1. Battista RA,
   2. Littlefield PD.,
   3. Revision BAHA

   (8, 2006) Surgery. Otolaryngol Clin North Am 39(4):801–813, pmid:16895786, viii.

   OpenUrlCrossRefPubMed
5. ↵
   1. House JW,
   2. Kutz JW Jr.

   (2, 2007) Bone-anchored hearing aids: incidence and management of postoperative complications. Otol Neurotol 28(2):213–217, pmid:17255890.

   OpenUrlCrossRefPubMed
6. ↵
   1. Wilkinson EP,
   2. Luxford WM,
   3. Slattery WH 3rd.,
   4. De la Cruz A,
   5. House JW,
   6. Fayad JN.

   (4, 2009) Single vertical incision for Baha implant surgery: preliminary results. Otolaryngol Head Neck Surg 140(4):573–578, pmid:19328349.

   OpenUrlCrossRefPubMed
7. ↵
   1. Badran K,
   2. Arya AK,
   3. Bunstone D,
   4. Mackinnon N.

   (2, 2009) Long-term complications of bone-anchored hearing aids: a 14-year experience. J Laryngol Otol 123(2):170–176, pmid:18492306, doi: 10.1017/S0022215108002521.

   OpenUrlCrossRefPubMed
8. ↵
   1. Lustig LR,
   2. Arts HA,
   3. Brackmann DE,
   4. et al.

   (5, 2001) Hearing rehabilitation using the BAHA bone-anchored hearing aid: results in 40 patients. Otol Neurotol 22(3):328–334, pmid:11347635.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   1. Medicaid

   (2015) Survey of Retail Prices, http://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Benefits/Prescription-Drugs/Survey-of-Retail-Prices.html, Accessed June 1.
10. ↵
    1. Long CC,
    2. Finlay AY.

    (11, 1991) The finger-tip unit—a new practical measure. Clin Exp Dermatol 16(6):444–447, pmid:1806320.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Graham-Field

    (2015) Grafco Silver Nitrate Applicators, http://www.grahamfield.com/Medical_Product/Grafco__Silver_Nitrate_Applicators.aspx?b=0&s=0&c=0&g=0&p=174&v=1, Accessed June 1.
12. ↵
    1. Centers for Medicare & Medicaid Services

    (2015) 2013 ASP Drug Pricing Files, http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/2013ASPFiles.html, Accessed June 1.
13. ↵
    1. U.S. Department of Health & Human Services

    (2015) HCUPnet, http://hcupnet.ahrq.gov, Accessed June 1.